These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 4258979)

  • 1. Reserpine-induced alterations in brain amines and their relationship to changes in the incidence of minimal electroshock seizures in mice.
    Azzaro AJ; Wenger GR; Craig CR; Stitzel RE
    J Pharmacol Exp Ther; 1972 Mar; 180(3):558-68. PubMed ID: 4258979
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of biogenic amines in the reserpine-induced alteration of minimal electroshock seizure thresholds in the mouse.
    Wenger GR; Stitzel RE; Craig CR
    Neuropharmacology; 1973 Jul; 12(7):693-703. PubMed ID: 4147164
    [No Abstract]   [Full Text] [Related]  

  • 3. Neurochemical changes following the administration of depleters of biogenic monoamines.
    Lane JD; Smith JE; Shea PA; McBride WJ
    Life Sci; 1976 Dec; 19(11):1663-7. PubMed ID: 12434
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of the effectiveness of deserpidine, reserpine, and alpha-methyltyrosine on brain biogenic amines.
    Fulton SC; Healy MD
    Fed Proc; 1976 Dec; 35(14):2558-62. PubMed ID: 11134
    [No Abstract]   [Full Text] [Related]  

  • 5. Histochemical fluorescence detection of changes in central monoamine neurones provoked by drugs acting on the CNS.
    Fuxe K; Hökfelt T
    Triangle; 1971; 10(3):73-84. PubMed ID: 5138525
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of reserpine, alpha-methyl-m-tyrosine, prenylamine, and guanethidine on metrazol-convulsions and the brain monoamine level in mice.
    Pfeifer AK; Galambos E
    Arch Int Pharmacodyn Ther; 1967 Jan; 165(1):201-11. PubMed ID: 6030237
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of deserpidine and pargyline on the levels of biogenic amines in brain, liver and heart of mice.
    Everett GM; Borcherding J; Morse P
    Res Commun Chem Pathol Pharmacol; 1972 Mar; 3(2):245-8. PubMed ID: 4679851
    [No Abstract]   [Full Text] [Related]  

  • 8. Some effects of dl-4-(2-hydroxy-3-isopropylaminopropoxy) indole (LB46) on brain monoamines and their precursors.
    Leonard BE
    Arch Int Pharmacodyn Ther; 1972 Sep; 199(1):79-93. PubMed ID: 5072194
    [No Abstract]   [Full Text] [Related]  

  • 9. [Gas chromatographic analysis of central biogenic amines and its application. 1].
    Maruyama Y; Hosoya E; Takemori AE
    Nihon Yakurigaku Zasshi; 1973 Sep; 69(5):661-72. PubMed ID: 4271692
    [No Abstract]   [Full Text] [Related]  

  • 10. The relationship between magnitude of electroshock stimulation and the effects of digitoxigenin, pentylenetetrazol and brain monoamine reduction on electroshock convulsive thresholds.
    Buterbaugh GG; London ED
    Neuropharmacology; 1977 Sep; 16(9):617-23. PubMed ID: 144247
    [No Abstract]   [Full Text] [Related]  

  • 11. Pyridoxine dependency and central nervous system excitability.
    Schlesinger K; Uphouse LL
    Adv Biochem Psychopharmacol; 1972; 4():105-40. PubMed ID: 4555926
    [No Abstract]   [Full Text] [Related]  

  • 12. The possible role of brain monoamines in the acute toxicity of digitoxigenin.
    Buterbaugh GG; Spratt JL
    J Pharmacol Exp Ther; 1970 Oct; 175(1):121-30. PubMed ID: 4394300
    [No Abstract]   [Full Text] [Related]  

  • 13. Evidence of a role for brain monoamines in ethanol dependence.
    Griffiths PJ; Littleton JM; Oritz A; Brownlee G
    Br J Pharmacol; 1973 Jun; 48(2):354P. PubMed ID: 4147432
    [No Abstract]   [Full Text] [Related]  

  • 14. Central nervous system effects of fenfluramine hydrochloride.
    Ziance RJ; Sipes IG; Kinnard WJ; Buckley JP
    J Pharmacol Exp Ther; 1972 Jan; 180(1):110-7. PubMed ID: 5062254
    [No Abstract]   [Full Text] [Related]  

  • 15. Audiogenic seizures in mice: influence of agents affecting brain serotonin.
    Alexander GJ; Kopeloff LM
    Res Commun Chem Pathol Pharmacol; 1976 Jul; 14(3):437-48. PubMed ID: 134436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biogenic amines and narcotic effects. I. Modification of morphine-induced analgesia and motor activity after alteration of cerebral amine levels.
    Buxbaum DM; Yarbrough GG; Carter ME
    J Pharmacol Exp Ther; 1973 May; 185(2):317-27. PubMed ID: 4267383
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of catecholamine synthesis inhibition on ethanol narcosis in mice.
    Blum K; Merritt JH; Wallace JE; Owen R; Hahn JW; Geller I
    Curr Ther Res Clin Exp; 1972 Jun; 14(6):324-9. PubMed ID: 4625804
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of biogenic amines in amygdalar kindling. I. Local amygdalar afterdischarge.
    Wilkison DM; Halpern LM
    J Pharmacol Exp Ther; 1979 Oct; 211(1):151-8. PubMed ID: 158641
    [No Abstract]   [Full Text] [Related]  

  • 19. Serotonin and behavior: a brief summary.
    Aprison MH; Hingtgen JN
    Fed Proc; 1972; 31(1):121-9. PubMed ID: 4333248
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma corticosterone changes following alterations in brain norepinephrine and serotonin.
    McKinney WT; Prange AJ; Majchowicz E; Schlesinger K
    Dis Nerv Syst; 1971 May; 32(5):308-13. PubMed ID: 4397134
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.